Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
SCIENCE
May 11, 202131 min read, 6242 words

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccinationAdjuvant oncolytic virotherapy for personalized anti-cancer vaccination

Published: May 11, 2021  |  31 min read, 6242 words
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtainthe best experience, we recommend you use a more up to date browser (or turn off compatibility mode inInternet Explorer). In the meantime, to ensure continued support, we are...
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.